Anshika Jain
Modern healthcare increasingly depends on measurable indicators to understand biological processes, assess disease risk, monitor treatment outcomes, and evaluate changes in a person’s health. Blood glucose can help assess glucose regulation, blood pressure can indicate cardiovascular risk, and cholesterol measurements can contribute to an evaluation of lipid metabolism. However, not every biological process can be measured directly, continuously, or affordably. Researchers and clinicians therefore often rely on biomarkers and proxy measurements to estimate what is happening inside the body.
A proxy measurement is an observable indicator used to approximate another variable that is more difficult, expensive, invasive, or impractical to measure. In medical research, a biomarker may serve as a proxy for a biological process, while a clinical measurement may be used to estimate a broader health condition. These substitutions can make healthcare more accessible and research more efficient, but they also introduce a critical question: how reliably does one measurement represent another?
The relationship between two measurements is rarely universal. A biomarker that closely tracks a biological process in one population may become less informative in another. A measurement that works well during the early stages of a condition may lose predictive value as the disease progresses. Similarly, a proxy that performs adequately in a controlled research setting may become unreliable when applied to patients with different ages, medications, dietary habits, genetic backgrounds, or coexisting conditions.
Biomarker Substitution Intelligence explores how artificial intelligence can help determine when one measurement is a trustworthy substitute for another and when that substitution could produce misleading conclusions. Rather than simply identifying correlations, AI systems could evaluate the conditions under which a proxy remains valid, detect changes in its reliability, quantify uncertainty, and recommend when a direct measurement or alternative biomarker is necessary.
This approach could contribute to more dependable clinical research, personalized monitoring, preventive healthcare, and evidence-based decision-making. Its value, however, depends on distinguishing statistical association from biological meaning and ensuring that algorithmic recommendations are validated before they influence patient care.
Understanding Biomarkers, Proxies, and Measurement Substitution
What Makes a Measurement a Proxy?
A proxy is a variable used to estimate another variable that cannot be observed easily or directly. In healthcare, this substitution may be necessary because the underlying biological process is difficult to access, requires expensive equipment, or changes too quickly for conventional testing. Researchers may also use proxy measurements when historical datasets do not contain the precise variable needed for a particular analysis.
For example, body mass index is frequently used as a practical indicator of body size relative to height. It can help researchers study population-level patterns, but it does not directly measure body fat distribution, muscle mass, or metabolic health. Two people with the same body mass index may have substantially different body compositions and health risks. Consequently, the usefulness of the measurement depends on the question being asked and the population being evaluated.
A similar distinction appears in nutrition research. Dietary records may be used to estimate nutrient intake, but reported consumption does not perfectly represent the quantity absorbed by the body. Differences in digestion, food preparation, medication use, gut function, and individual metabolism can affect the relationship between recorded intake and biological exposure.
In each case, the proxy is not necessarily incorrect. It is a simplified representation with specific strengths and limitations. The central challenge is determining whether those limitations matter for the intended application.
Why Proxy Relationships Can Break Down
Two measurements may appear closely related because they share a biological mechanism, respond to similar external influences, or happen to correlate within a particular dataset. However, their relationship may change when the underlying conditions change.
A biomarker may respond to multiple biological processes at once. If one process dominates in a particular population, the marker may appear to represent it accurately. In another population, a different process may influence the same marker, weakening its interpretability. Medication, inflammation, hydration, age, or organ function may also alter the relationship.
Proxy reliability can therefore be context-dependent. A measurement suitable for screening may not be suitable for diagnosing a condition, and a marker useful for predicting future risk may not accurately reflect whether a treatment is working. Predictive accuracy and biological representation are related but distinct properties.
Biomarker Substitution Intelligence seeks to make these distinctions explicit. Instead of assuming that a relationship remains stable because it was observed previously, an AI system would evaluate the circumstances in which that relationship holds and identify situations in which it requires reconsideration.
How AI Could Evaluate Biomarker Substitution Reliability
Learning Relationships Between Multiple Measurements
Artificial intelligence can analyze large datasets containing laboratory results, clinical observations, demographic characteristics, treatment histories, wearable-device measurements, and longitudinal health records. By comparing measurements across individuals and time, machine-learning models can identify patterns that may be difficult to detect through conventional statistical analysis alone.
Suppose a research team wants to determine whether an inexpensive blood marker can approximate a more complex laboratory measurement. An AI model could examine how closely the two measurements correspond across different age groups, disease stages, medication categories, and physiological conditions. It could also investigate whether the relationship remains consistent over repeated observations rather than relying on a single measurement.
This distinction matters because a strong average relationship can conceal important exceptions. A proxy may perform well for most participants but produce substantial errors in a smaller group. An overall correlation coefficient might not reveal whether those errors are concentrated among people who already face greater health risks.
A more comprehensive evaluation would examine prediction errors, calibration, subgroup performance, temporal stability, and the consequences of incorrect substitution. The goal would not simply be to identify two related measurements but to estimate how dependable the substitution is for a particular purpose.
Distinguishing Correlation From Biological Equivalence
One of the most important responsibilities of a biomarker intelligence system would be distinguishing correlation from equivalence. Two measurements can move together without representing the same biological process. They may share an external influence, or one may be associated with an outcome without directly reflecting the mechanism responsible for it.
For example, a biomarker could correlate with disease severity because both are influenced by inflammation. This does not automatically establish that the biomarker accurately measures the disease process itself. If inflammation changes for another reason, the relationship may weaken even when the underlying condition remains unchanged.
AI can help identify these complexities by comparing competing explanations, evaluating known biological relationships, and testing whether a proxy retains its association under different conditions. Causal inference methods may provide additional insights when suitable data and assumptions are available. Nevertheless, observational patterns alone cannot establish causality, and algorithmic confidence should never be treated as proof of biological equivalence.
A reliable system would combine statistical evidence with clinical knowledge, experimental findings, and independent validation. Where the evidence remains insufficient, it should report uncertainty instead of presenting a proxy as interchangeable with a direct measurement.
The Role of Context-Aware Biomarker Intelligence
Why One Proxy May Not Work for Every Patient
Conventional reference ranges and population-level models provide useful starting points, but biological variation can make a single substitution rule unsuitable for everyone. A proxy measurement may behave differently depending on age, sex, nutritional status, medication exposure, genetic variation, kidney or liver function, and the stage of a disease. These factors can change either the underlying biological process or the way a measurement reflects it.
Context-aware AI could estimate proxy reliability across clinically meaningful subgroups. Rather than declaring a measurement universally reliable, the system could identify where evidence supports its use, where accuracy deteriorates, and where additional validation is required.
Consider a hypothetical model designed to estimate a complex metabolic indicator using a less expensive laboratory marker. The model might perform well in generally healthy adults but become less accurate among people taking certain medications or experiencing substantial changes in organ function. An aggregate performance score could obscure these differences. A context-aware system would examine them directly and communicate that the substitution is less dependable in the affected groups.
This capability could help researchers design more representative studies and help clinicians understand when a result needs further investigation. It could also reduce the risk of treating population averages as reliable descriptions of every individual.
However, personalization must be approached carefully. A model should not assume that demographic characteristics automatically determine biological behavior. It needs sufficient representative data, appropriate validation, and transparent reasoning about which factors influence its predictions.
Detecting When a Previously Reliable Proxy Becomes Unreliable
Proxy relationships can change over time, even when the same person is being monitored. Disease progression, treatment changes, acute illness, nutritional changes, or alterations in organ function may affect the relationship between two measurements. A proxy that was informative during one period may become less useful during another.
Longitudinal AI systems could evaluate this possibility by examining repeated measurements and identifying deviations from an individual’s established pattern. If a proxy begins to diverge from occasional direct measurements, the model could flag the discrepancy and estimate whether the change exceeds expected measurement variability.
For instance, a wearable device may provide a useful estimate of a physiological parameter during ordinary daily activity. Its accuracy might decline during unusual movement, poor sensor contact, or changes in circulation. An intelligent monitoring system could identify conditions associated with increased estimation error and indicate when the reading should not be interpreted with its usual confidence.
The same principle applies to laboratory biomarkers. If a model observes that a proxy’s relationship with a reference measurement has changed after a treatment intervention, it could prompt a review of the substitution rule. This would help prevent outdated assumptions from remaining embedded in clinical workflows.
Such monitoring requires a carefully designed reference process. An AI system cannot reliably detect every substitution failure using only the proxy itself, because it may have no independent evidence of the true underlying value. Periodic direct measurements, external validation data, or clinically established reference methods may be necessary to determine whether the relationship has genuinely changed.
Biomarker Substitution Intelligence in Nutrition and Metabolic Research
The Gap Between Nutrient Intake and Biological Response
Nutrition offers a particularly useful setting for studying proxy reliability because food intake, nutrient absorption, metabolism, and physiological outcomes are connected but not interchangeable. Researchers frequently use dietary questionnaires, food diaries, nutrient databases, blood measurements, and other indicators to estimate different parts of this chain.
A dietary questionnaire can provide information about habitual food consumption, but it may not accurately capture portion sizes, preparation methods, forgotten meals, or variations in food composition. Even a relatively accurate estimate of nutrient intake does not directly establish how much of that nutrient was absorbed or how the body used it.
Similarly, a blood concentration may reflect recent intake, internal regulation, storage, transport, or elimination rather than simply representing the amount consumed. The meaning of a biomarker depends on the nutrient involved and the physiological context in which it is measured.
AI could evaluate the relationship between reported intake, measured nutrient status, relevant physiological variables, and longer-term outcomes. It might identify which dietary indicators are informative for particular research questions and which introduce substantial uncertainty. It could also examine whether the relationship differs across populations with different dietary patterns or health characteristics.
This would be valuable for precision nutrition, where the same dietary intervention can produce different responses in different people. Rather than assuming that a dietary record predicts a biological response equally well for everyone, researchers could estimate the reliability of that relationship and identify circumstances in which additional measurements are needed.
Evaluating Glucose, Insulin, and Other Metabolic Indicators
Metabolic research illustrates why related biomarkers should not be treated as substitutes without careful evaluation. Blood glucose, insulin concentration, and glycated hemoglobin provide different kinds of information about glucose regulation. They are related, but each captures a distinct aspect of physiology or a different time window.
A single glucose measurement reflects conditions at a particular moment and may be influenced by recent meals, activity, stress, illness, and medication. Glycated hemoglobin generally provides information about longer-term average glucose exposure, although conditions affecting red blood cell turnover can influence its interpretation. Insulin measurements provide additional information about hormonal responses but also depend on the timing of sampling and the individual’s physiological state.
An AI model could investigate whether one measurement predicts another accurately under defined conditions. It could estimate where a substitution is acceptable for exploratory analysis and where the differences between the measurements are too important to ignore.
For example, a model trained to estimate a longer-term metabolic indicator from occasional glucose readings might perform well in one dataset but fail when readings are collected at inconsistent times or when the population includes conditions that affect glucose regulation differently. Biomarker Substitution Intelligence would examine these limitations rather than assuming that more data automatically creates a dependable estimate.
The objective would not be to eliminate established tests. It would be to determine when a proxy offers useful information, when it requires additional context, and when direct measurement remains essential.
Applications Beyond Nutrition
Early Disease Detection and Preventive Healthcare
Many diseases develop gradually, and early biological changes may be difficult to detect using conventional testing alone. Researchers may investigate accessible biomarkers as proxies for more complex physiological processes in the hope of improving early identification and risk assessment.
AI could compare candidate proxies against established reference measurements and evaluate whether their performance remains consistent across different stages of disease. It could also assess the trade-off between convenience and accuracy. A low-cost proxy may be suitable for preliminary screening if its limitations are understood, while a more specific test may be required before making a diagnosis or initiating treatment.
This distinction is especially important when false positives and false negatives have different consequences. An unreliable proxy could create unnecessary concern, delay appropriate investigation, or produce false reassurance. Therefore, substitution decisions should consider not only average predictive performance but also the clinical consequences of errors.
An intelligent system could support decisions about when an initial result is sufficiently informative and when confirmatory testing is necessary. Such systems would need prospective evaluation to establish whether they improve clinical outcomes rather than merely improving statistical performance.
Wearable Devices and Remote Patient Monitoring
Wearable devices generate continuous or frequent measurements that can be more convenient than repeated laboratory tests. Heart rate, movement, skin temperature, and other sensor-derived signals may be used to estimate aspects of sleep, recovery, physical activity, or physiological stress.
However, sensor readings are affected by device placement, movement, environmental conditions, skin contact, individual physiology, and the algorithms used to process raw signals. A value generated by a consumer device may not be directly equivalent to a clinical measurement, even when the two are strongly correlated under controlled conditions.
Biomarker Substitution Intelligence could evaluate when sensor-derived estimates are sufficiently reliable for a defined monitoring task. It could identify conditions in which signal quality deteriorates and distinguish a meaningful physiological change from a possible measurement artifact.
For example, a wearable may estimate a physiological parameter accurately during rest but less reliably during vigorous exercise. Rather than presenting both readings with equal confidence, a context-sensitive model could communicate the difference and indicate when the result should be interpreted cautiously.
This approach could improve remote monitoring, provided that consumer-device estimates are not misrepresented as diagnostic measurements and that the system clearly communicates uncertainty.
Clinical Trials and Research Cost Optimization
Clinical trials often require expensive, invasive, or time-consuming measurements. If a less burdensome proxy could reliably estimate a research variable, it might reduce participant discomfort, lower costs, or allow more frequent data collection.
AI could help researchers screen candidate proxies and determine whether they are sufficiently accurate for the intended research purpose. It could also identify cases in which substitution would compromise the study’s conclusions.
Importantly, a proxy that predicts an outcome well may not be suitable as a surrogate endpoint for a clinical trial. A treatment might improve the biomarker without improving how patients feel, function, or survive. Establishing that a surrogate endpoint reliably captures treatment effects generally requires strong evidence across relevant studies, not merely a correlation between the biomarker and the outcome.
An AI model could organize and evaluate this evidence, identify inconsistencies, and help prioritize further validation. It should not independently declare a surrogate endpoint clinically valid without the necessary scientific and regulatory assessment.
Building an AI System for Biomarker Substitution Intelligence
Integrating High-Quality Data and Reference Measurements
The effectiveness of a biomarker substitution model depends on the quality and diversity of its training data. A system cannot reliably assess whether one measurement substitutes for another if the dataset contains only one of them, lacks relevant contextual information, or represents a narrow population.
Researchers would ideally assemble datasets containing both the proposed proxy and the reference measurement, collected under clearly documented conditions. Repeated measurements would help establish whether the relationship is stable over time, while information about treatments, health conditions, sampling procedures, and measurement equipment could help explain differences in performance.
Reference measurements also require scrutiny. A measurement used as a comparison standard may itself contain errors or limitations. In some fields, no single test perfectly captures the biological process of interest. An AI system should therefore distinguish uncertainty in the proxy from uncertainty in the reference standard.
Data harmonization is another important requirement. Different laboratories may use different equipment, calibration procedures, or measurement protocols. Wearable devices may apply different processing algorithms, and research studies may define variables inconsistently. Without careful harmonization, an AI model may learn differences between measurement systems rather than meaningful biological relationships.
Combining Machine Learning With Statistical Validation
Several analytical approaches could contribute to biomarker substitution intelligence. Regression models can estimate relationships between measurements, while nonlinear machine-learning techniques can capture more complex patterns. Bayesian methods can represent uncertainty, and subgroup analysis can identify populations in which a proxy performs differently. Time-series models can investigate whether relationships change during longitudinal monitoring.
No single technique is sufficient for every application. A complex model may detect subtle relationships but be difficult to interpret, while a simpler model may offer greater transparency but fail to capture important nonlinear effects. The appropriate method depends on the biological question, available data, consequences of error, and need for interpretability.
Validation should include more than testing performance on a random subset of the original dataset. Researchers should evaluate models on independent populations, different clinical settings, and, where relevant, data collected at later points in time. This helps determine whether a substitution rule generalizes beyond the environment in which it was developed.
The system should also assess calibration, prediction error, subgroup performance, and the reliability of its uncertainty estimates. If it cannot establish that a proxy is dependable for a particular context, it should communicate that limitation rather than generate a confident but unsupported estimate.
Creating a Reliability Score That Supports Decisions
One potential development is a biomarker substitution reliability score that summarizes the evidence supporting a proposed measurement relationship. Such a score could incorporate prediction accuracy, calibration, data quality, population similarity, temporal stability, and the consequences of incorrect substitution.
However, a single numerical score could oversimplify a complex decision. A proxy might be statistically accurate but biologically inappropriate for a particular purpose. Another might perform well for screening but be unsuitable for diagnosis. Reliability therefore needs to be evaluated relative to a clearly defined task.
A practical system could combine a quantitative estimate with an explanation of the conditions under which the substitution is supported. It might indicate that a proxy is well validated for a particular population, requires additional evidence in another population, or should not replace a reference measurement when treatment decisions depend on precise values.
This approach would make the output more actionable than a generic prediction. It would also help clinicians and researchers understand why the model supports or rejects a substitution.
Challenges, Limitations, and Ethical Considerations
The Danger of Overconfident Predictions
AI systems can identify patterns without fully understanding the biological mechanisms responsible for them. A model may learn that two measurements are strongly associated in its training data and then incorrectly assume that the relationship remains valid in unfamiliar conditions.
This problem becomes particularly serious when predictions are presented as replacements for direct measurements. If an estimated value appears precise, users may overlook uncertainty in the underlying relationship. The resulting decision could be based on a proxy that is no longer representative of the target variable.
A responsible system should communicate the limits of its evidence, identify situations outside its validated scope, and avoid recommending substitution when the consequences of error are unacceptable. It should also allow clinicians and researchers to examine the assumptions behind its recommendations.
Population Bias and Unequal Reliability
Biomarker datasets may disproportionately represent certain age groups, geographic regions, clinical populations, or socioeconomic backgrounds. If an AI model is trained primarily on one group, it may incorrectly estimate proxy reliability for people whose biological characteristics or healthcare circumstances differ.
This is not simply a technical concern. If a proxy performs poorly for an underrepresented population, using it as a substitute could produce systematically less reliable assessments for those individuals.
Researchers should therefore evaluate performance across relevant populations and investigate why differences occur. In some cases, additional data may improve reliability. In others, the proposed proxy may not be appropriate for the population at all.
Fairness does not require every proxy to be used universally. It requires evidence-based decisions, transparent limitations, and access to alternative measurements when a particular substitution is unreliable.
Privacy, Governance, and Clinical Accountability
Biomarker substitution models may require sensitive laboratory results, longitudinal health records, medication histories, and wearable-device data. Protecting these records is essential, particularly when information from multiple healthcare providers or research institutions is combined.
Privacy-preserving approaches, including federated learning and carefully designed data-sharing arrangements, may help researchers evaluate measurement relationships without centralizing every record. However, these approaches still require appropriate security controls, governance, and assessment of potential privacy risks.
Clinical accountability is equally important. An AI recommendation should not obscure who is responsible for interpreting a result or deciding whether a direct test is necessary. Healthcare professionals must be able to understand the intended use of a proxy, review the supporting evidence, and override an automated recommendation when the clinical context demands it.
Regulatory requirements may also apply when a system is intended to influence diagnosis, monitoring, or treatment. The level of evidence and oversight should reflect the intended use and the potential harm resulting from an incorrect substitution.
The Future of Biomarker Substitution Intelligence
The next stage of biomarker intelligence may involve systems that continuously evaluate the validity of measurement relationships rather than treating them as permanent scientific assumptions. These systems could combine laboratory testing, wearable sensors, clinical observations, biological knowledge, and longitudinal records to assess whether a proxy remains appropriate as circumstances change.
For example, a future monitoring platform could estimate a target variable using an accessible proxy, track the uncertainty of that estimate, and identify when the relationship has become less reliable. It could then recommend a confirmatory measurement or request professional review. In research settings, similar systems could identify promising low-cost indicators and prioritize the studies needed to establish their validity.
Such capabilities could make research more efficient, reduce unnecessary testing in appropriate circumstances, and improve the interpretation of health data. Yet these benefits depend on maintaining a clear distinction between estimating a variable and measuring it directly. Greater computational power does not eliminate biological complexity, measurement error, or the need for scientific validation.
The most useful systems will therefore combine AI-driven pattern recognition with rigorous experimental evidence, transparent uncertainty estimates, and human oversight. Their purpose should not be to replace every expensive or inconvenient test with a cheaper approximation. Instead, they should help determine when substitution is scientifically justified and when the original measurement remains necessary.
Conclusion: Knowing When a Measurement Can No Longer Be Trusted
Biomarker Substitution Intelligence represents a promising direction for AI-assisted healthcare and biomedical research. By evaluating relationships between measurements across populations, conditions, and time, AI could help identify when a proxy provides dependable information and when it risks creating a misleading picture of biological reality.
Its central contribution is not simply predicting an unavailable measurement. It is evaluating the validity of the prediction itself. This requires attention to biological context, measurement quality, uncertainty, population diversity, and the clinical purpose for which the proxy will be used.
In nutrition research, the approach could clarify the relationship between reported dietary intake and biological response. In preventive healthcare, it could help evaluate accessible indicators for early screening. In wearable monitoring, it could distinguish reliable estimates from readings affected by poor signal quality. In clinical trials, it could support the assessment of candidate surrogate measurements while preserving the need for rigorous evidence.
Ultimately, a trustworthy AI system should recognize that not every correlated measurement is interchangeable. By identifying the boundaries of reliable substitution, Biomarker Substitution Intelligence could help healthcare professionals and researchers make better-informed decisions about what to measure, what can be estimated, and when uncertainty makes a direct measurement essential.